🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Aim of this study is to investigate effectiveness of myofascial releasing o...
Status
Completed
Location
Abant Izzet Baysal University
Start Date
2018-08-12
Trial ID
NCT03585283
Treatments Being Tested
This will be a double-blind, 4-period, randomized, cross-over study conduct...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01-10
Trial ID
NCT01756495
Treatments Being Tested
The objective of this study was to evaluate the specific effect of a simple...
Status
Completed
Location
First Hospital of China Medical University
Start Date
2023-07-31
Trial ID
NCT06787287
Treatments Being Tested
The purpose of this study is to evaluate the relative bioavailability and f...
Status
Completed
Location
PRA Health Sciences
Start Date
2021-04-14
Trial ID
NCT04844424
Treatments Being Tested
Hemostasis at the arterial puncture site after percutaneous coronary interv...
Status
Completed
Location
St. Michael's Hospital
Start Date
2006-07
Trial ID
NCT00264264
Treatments Being Tested
To examine morphological and functional results after pars plana vitrectomy...
Status
Completed
Location
General Department of Ophthalmology in Lublin
Start Date
2016-03
Trial ID
NCT03902795
Treatments Being Tested
Osteoporotic vertebral compression fractures (OVCFs) are a common and serio...
Status
Recruiting
Location
Tri-Service General Hospital, National Defense Medical Univesity
Start Date
2021-04-20
Trial ID
NCT07665424
Treatments Being Tested
This study is a Phase I, randomized, open-label, cross-over study with 4 si...
Status
Completed
Location
SGS Belgium Life Sciences
Start Date
2017-04-14
Trial ID
NCT03143725
Treatments Being Tested
Arterial puncture is a common procedure in the management of hospitalized p...
Status
Not Yet Recruiting
Location
CHU Orléans
Start Date
2026-09
Trial ID
NCT07765199
Treatments Being Tested
Epelsiban is a potent and selective oxytocin receptor antagonist in develop...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-18
Trial ID
NCT02257359
Treatments Being Tested